Physician profile
Sanjay Bhambri
NPI 1275702656
$238.60
in general payments reported to CMS, 2019-2025
10 companies · $5.99 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.58 · 2022: $35.39 · 2023: $119 · 2024: $16.30 · 2025: $5.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $90.00 · Food and Beverage: $51.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $90.00 |
| Food and Beverage | $51.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $90.00 | 2023 | Tremfya |
| Journey Medical Corporation | $35.39 | 2022 | |
| Dermira, INC. | $21.71 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.30 | 2024 | Sotyktu |
| Dermavant Sciences, INC. | $15.45 | 2023 | Vtama |
| Abbvie INC. | $14.60 | 2019 | |
| Mayne Pharma Commercial LLC | $14.22 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.89 | 2023 | Dupixent |
| Merck Sharp & Dohme LLC | $11.05 | 2019 | |
| Organon LLC | $5.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Bhambri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.